A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19

Drifa Belhadi, Nathan Peiffer-Smadja, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, Cédric Laouénan
doi: https://doi.org/10.1101/2020.03.18.20038190

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.

Back to top
Posted March 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
Drifa Belhadi, Nathan Peiffer-Smadja, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentré, Cédric Laouénan
medRxiv 2020.03.18.20038190; doi: https://doi.org/10.1101/2020.03.18.20038190
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area